Needle or Drip?—Real-World Comparison of Intravenous to Subcutaneous Infliximab and Vedolizumab in the Management of Inflammatory Bowel Diseases.

Saved in:
Bibliographic Details
Title: Needle or Drip?—Real-World Comparison of Intravenous to Subcutaneous Infliximab and Vedolizumab in the Management of Inflammatory Bowel Diseases.
Authors: Outtier, An1,2 (AUTHOR) An.outtier@uzleuven.be, Ferrante, Marc1,2 (AUTHOR) Marc.ferrante@uzleuven.be
Source: Digestive Diseases & Sciences. Jan2025, Vol. 70 Issue 1, p17-18. 2p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:01632116
DOI:10.1007/s10620-024-08772-4